Avertix Medical Inc. signed a definitive merger agreement with Bios Acquisition Corp., a special purpose acquisition company (SPAC), in a deal that will take the company public on the Nasdaq. The deal will establish the combined entity, which will continue under the Avertix name and trade as AVRT, with an estimated enterprise value of $195 million. The transaction is expected to close in the second half of the year. Read More
Pattern Bioscience Inc. reeled in $28.7 million in a series C financing led by Illumina Ventures and Omnimed Capital. The money will be used to complete development of its rapid phenotypic test platform for infectious diseases, conduct clinical validation studies and submit the platform and Pattern’s initial test, for pneumonia, for U.S. FDA review. Read More
Med-tech companies are facing a new reality of high interest rates, inflation, bank failures, and geopolitical turmoil that are impacting financing and M&A opportunities. To secure finance and attract partnership deals they must keep their product simple, focus on proof of concept and ensure that it has quality, delegates at the LSX World Congress in London heard during a panel presentation. Read More
A non-invasive method has been developed for decoding speech from brain patterns captured by functional magnetic resonance imaging (fMRI) data. Read More
Blood clots can lead to life-threatening conditions such as deep vein thrombosis, heart attack, pulmonary embolism and stroke. Blood thinners are essential in the treatment and prevention of blood clots but carry a significant risk of bleeding as they target enzymes essential for blood clotting. Researchers at the University of British Columbia (UBC) and the University of Michigan have developed a new class of blood thinners that can specifically target clots without increasing the risk of bleeding. Read More
Med-tech firms raising money in public or private financings, including: Bone Health Technologies, Convergent, Dexcom, Heartbeam, Magenta Medical. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle, Kalos, Neurosense, Photocure, Smartlens, Widex. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acuitymd, Adagio, Femselect, Labcorp, Metafora, Obviohealth. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Centricity Vision, Femasys. Read More
